Director

Paul Graves

Director (Former Chief Executive Officer, Rio Tinto Lithium)·Charles River Laboratories International, Inc.

About

P

a

u

l

G

r

a

v

e

s

i

s

t

h

e

f

o

r

m

e

r

C

h

i

e

f

E

x

e

c

u

t

i

v

e

O

f

f

i

c

e

r

o

f

R

i

o

T

i

n

t

o

L

i

t

h

i

u

m

(

p

r

e

v

i

o

u

s

l

y

A

r

c

a

d

i

u

m

L

i

t

h

i

u

m

u

n

t

i

l

i

t

w

a

s

a

c

q

u

i

r

e

d

b

y

R

i

o

T

i

n

t

o

i

n

M

a

r

c

h

2

0

2

5

)

.

P

r

e

v

i

o

u

s

l

y

,

M

r

.

G

r

a

v

e

s

s

e

r

v

e

d

a

s

C

h

i

e

f

E

x

e

c

u

t

i

v

e

O

f

f

i

c

e

r

o

f

L

i

v

e

n

t

C

o

r

p

o

r

a

t

i

o

n

a

n

d

w

a

s

a

n

i

n

t

e

g

r

a

l

p

a

r

t

o

f

t

h

e

m

e

r

g

e

r

w

i

t

h

A

l

l

k

e

m

L

i

m

i

t

e

d

t

h

a

t

c

r

e

a

t

e

d

A

r

c

a

d

i

u

m

L

i

t

h

i

u

m

.

E

a

r

l

i

e

r

,

h

e

w

a

s

E

x

e

c

u

t

i

v

e

V

i

c

e

P

r

e

s

i

d

e

n

t

a

n

d

C

h

i

e

f

F

i

n

a

n

c

i

a

l

O

f

f

i

c

e

r

o

f

F

M

C

C

o

r

p

o

r

a

t

i

o

n

.

B

e

f

o

r

e

j

o

i

n

i

n

g

F

M

C

,

h

e

w

a

s

a

p

a

r

t

n

e

r

a

t

G

o

l

d

m

a

n

S

a

c

h

s

,

s

e

r

v

i

n

g

i

n

a

v

a

r

i

e

t

y

o

f

r

o

l

e

s

i

n

c

l

u

d

i

n

g

a

s

H

e

a

d

o

f

N

a

t

u

r

a

l

R

e

s

o

u

r

c

e

s

f

o

r

A

s

i

a

a

n

d

G

l

o

b

a

l

H

e

a

d

o

f

C

h

e

m

i

c

a

l

I

n

v

e

s

t

m

e

n

t

B

a

n

k

i

n

g

.

M

r

.

G

r

a

v

e

s

s

e

r

v

e

d

o

n

t

h

e

b

o

a

r

d

o

f

A

r

c

a

d

i

u

m

L

i

t

h

i

u

m

u

n

t

i

l

i

t

s

a

c

q

u

i

s

i

t

i

o

n

b

y

R

i

o

T

i

n

t

o

,

a

n

d

a

l

s

o

p

r

e

v

i

o

u

s

l

y

s

e

r

v

e

d

o

n

t

h

e

b

o

a

r

d

s

o

f

L

i

v

e

n

t

a

n

d

L

y

d

a

l

l

,

I

n

c

.

H

e

h

a

s

b

e

e

n

a

d

i

r

e

c

t

o

r

o

f

C

h

a

r

l

e

s

R

i

v

e

r

s

i

n

c

e

M

a

y

2

0

2

5

.

H

i

s

q

u

a

l

i

f

i

c

a

t

i

o

n

s

t

o

s

e

r

v

e

a

s

a

d

i

r

e

c

t

o

r

i

n

c

l

u

d

e

h

i

s

s

i

g

n

i

f

i

c

a

n

t

e

x

e

c

u

t

i

v

e

l

e

a

d

e

r

s

h

i

p

a

n

d

p

u

b

l

i

c

c

o

m

p

a

n

y

b

o

a

r

d

e

x

p

e

r

i

e

n

c

e

,

a

s

w

e

l

l

a

s

i

n

v

e

s

t

m

e

n

t

b

a

n

k

i

n

g

a

n

d

M

&

A

e

x

p

e

r

t

i

s

e

.

M

r

.

G

r

a

v

e

s

q

u

a

l

i

f

i

e

s

a

s

a

n

"

a

u

d

i

t

c

o

m

m

i

t

t

e

e

f

i

n

a

n

c

i

a

l

e

x

p

e

r

t

"

u

n

d

e

r

S

E

C

g

u

i

d

e

l

i

n

e

s

.

Since May 2025
Age 55
Tenure 1 yr

Also at Charles River Laboratories International, Inc.

JF James C. Foster Chair, President and Chief Executive Officer BG Birgit Girshick Corporate Executive Vice President and Chief Operating Officer (Chief Executive Officer effective May 5, 2026) NA Nancy C. Andrews Director (Executive Vice President and Chief Scientific Officer, Boston Children's Hospital) SB Steven Barg Director (Global Co-Head of Engagement, Elliott Investment Management L.P.) AC Abraham Ceesay Director (Chief Executive Officer, Rapport Therapeutics) ME Mark Enyedy Director (Former President and Chief Executive Officer, ImmunoGen, Inc.)

Roles

Organization Role Dates Details
Charles River Laboratories International, Inc. Director (Former Chief Executive Officer, Rio Tinto Lithium) May 2025–present Current role
Rio Tinto Lithium (formerly Arcadium Lithium) Chief Executive Officer until Mar 2025 Arcadium Lithium was acquired by Rio Tinto in March 2025.
Livent Corporation Chief Executive Officer Integral to the merger with Allkem Limited that created Arcadium Lithium.
FMC Corporation Executive Vice President and Chief Financial Officer
Goldman Sachs Partner; Head of Natural Resources for Asia and Global Head of Chemical Investment Banking
Arcadium Lithium Chief Executive Officer 2024-2025
Goldman Sachs Partner

Related

Company Charles River Laboratories International, Inc. Company hub Person James C. Foster Chair, President and Chief Executive Officer Person Birgit Girshick Corporate Executive Vice President and Chief Operating Officer (Chief Executive Officer effective May 5, 2026) Person Nancy C. Andrews Director (Executive Vice President and Chief Scientific Officer, Boston Children's Hospital) Person Steven Barg Director (Global Co-Head of Engagement, Elliott Investment Management L.P.) Person Abraham Ceesay Director (Chief Executive Officer, Rapport Therapeutics) Person Mark Enyedy Director (Former President and Chief Executive Officer, ImmunoGen, Inc.) Person Reshema Kemps-Polanco Director (Executive Vice President and Chief Commercial Officer, Novartis US) Person George Llado, Sr. Director (Former Senior Vice President and Chief Information Officer, Alexion Pharmaceuticals, Inc.) Person Martin W. Mackay Director (Lead Independent Director; Co-Founder and Non-Executive Chair, Rallybio Corporation) Person Craig B. Thompson Director (President Emeritus and Former President and Chief Executive Officer, Memorial Sloan Kettering Cancer Center) Person Virginia M. Wilson Director (Retired Senior Executive Vice President and Chief Financial Officer, TIAA) Person Michael Knell Interim Chief Financial Officer, Corporate Senior Vice President, and Chief Accounting Officer Deal Charles River Laboratories International Agilux Laboratories 2016 Deal page Deal Charles River Laboratories International Argenta And Biofocus Cro Services Division Of Galapagos 2014 Deal page Deal Charles River Laboratories International Blue Stream Laboratories 2016 Deal page
Source: Charles River Laboratories International, Inc. SEC filings and official company website

See how VectorShift works for your firm

Request Demo